ArticleClinical pharmacokinetics2022

Drug-Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection.

Catia Marzolini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.